These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Speech treatment for Parkinson's disease. Ramig LO; Fox C; Sapir S Expert Rev Neurother; 2008 Feb; 8(2):297-309. PubMed ID: 18271714 [TBL] [Abstract][Full Text] [Related]
3. [Voice and speech problems in Parkinson's disease]. Artzi T; Yaretzky A Harefuah; 1989 Dec; 117(11):396-9. PubMed ID: 2620881 [No Abstract] [Full Text] [Related]
4. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Ramig LO; Fox C; Sapir S Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Parkinson hypophonia with percutaneous collagen augmentation. Berke GS; Gerratt B; Kreiman J; Jackson K Laryngoscope; 1999 Aug; 109(8):1295-9. PubMed ID: 10443836 [TBL] [Abstract][Full Text] [Related]
6. [Normalization of the Parkinsonian voice during sleep]. Martí Massó JF Neurologia; 2003 Mar; 18(2):116. PubMed ID: 12610762 [No Abstract] [Full Text] [Related]
10. Laryngeal electromyography in adults with Parkinson's disease and voice complaints. Zarzur AP; Duprat AC; Shinzato G; Eckley CA Laryngoscope; 2007 May; 117(5):831-4. PubMed ID: 17473678 [TBL] [Abstract][Full Text] [Related]
11. Evidence-based treatment of voice and speech disorders in Parkinson disease. Mahler LA; Ramig LO; Fox C Curr Opin Otolaryngol Head Neck Surg; 2015 Jun; 23(3):209-15. PubMed ID: 25943966 [TBL] [Abstract][Full Text] [Related]
12. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease. Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561 [TBL] [Abstract][Full Text] [Related]
13. [Multiple system atrophy speech assessment: study of five cases]. Knopp DB; Barsottini OG; Ferraz HB Arq Neuropsiquiatr; 2002 Sep; 60(3-A):619-23. PubMed ID: 12244402 [TBL] [Abstract][Full Text] [Related]
14. Glottographic measures before and after levodopa treatment in Parkinson's disease. Jiang J; Lin E; Wang J; Hanson DG Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835 [TBL] [Abstract][Full Text] [Related]
15. Life with communication changes in Parkinson's disease. Miller N; Noble E; Jones D; Burn D Age Ageing; 2006 May; 35(3):235-9. PubMed ID: 16540492 [TBL] [Abstract][Full Text] [Related]
16. [Contribution and limits of acoustic analysis of the voice and alaryngeal speech with a computerized system]. Crevier-Buchman L; Laccourreye O; Papon JF; Monfrais-Pfauwadel MC; Brasnu D Ann Otolaryngol Chir Cervicofac; 1996; 113(2):61-8. PubMed ID: 8999745 [TBL] [Abstract][Full Text] [Related]
17. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease. Dias AE; Barbosa ER; Coracini K; Maia F; Marcolin MA; Fregni F Acta Neurol Scand; 2006 Feb; 113(2):92-9. PubMed ID: 16411969 [TBL] [Abstract][Full Text] [Related]
18. Disorders of verbal expression in parkinsonism. Streifler M; Hofman S Adv Neurol; 1984; 40():385-93. PubMed ID: 6695616 [TBL] [Abstract][Full Text] [Related]
19. Voice analysis and videolaryngostroboscopy in patients with Parkinson's disease. Yücetürk AV; Yilmaz H; Eğrilmez M; Karaca S Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):290-3. PubMed ID: 12115074 [TBL] [Abstract][Full Text] [Related]
20. Speech treatment for Parkinson's disease. Trail M; Fox C; Ramig LO; Sapir S; Howard J; Lai EC NeuroRehabilitation; 2005; 20(3):205-21. PubMed ID: 16340101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]